Oyster point investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of oyster point pharma, inc. - oyst

New orleans--( business wire )--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of oyster point pharma, inc. (nasdaqgs: oyst) to viatris inc. (nasdaqgs: vtrs). under the terms of the proposed transaction, shareholders of oyster point will receive $11.00 in cash plus a contingent value right for a potential cash payment of up to $2.00 per share, for each share of oyster point that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the company.
VTRS Ratings Summary
VTRS Quant Ranking